IGFBP2 and breast carcinoma: Lu et al. [1] tested the sera of 184 advanced-stage breast carcinoma patients and 134 healthy controls for AAb response to p53, HER2, IGFBP-2, and TOPO2α, and the responses were used to construct receiver operating characteristic (ROC) curves.